Novel Insights into Skeletal Muscle Atrophy and Insulin Signaling

Researchers at the University of Birmingham have made groundbreaking discoveries regarding the mechanisms underlying skeletal muscle atrophy and insulin signaling. By investigating the molecular interactions between muscle RING-finger protein 1 (MuRF1) and tripartite motif-containing protein 72 (TRIM72), the team shed new light on the complex relationships between muscle atrophy and impaired insulin sensitivity. The study, published in The FASEB Journal, highlights the critical role of MuRF1 in facilitating skeletal muscle atrophy and insulin signaling impairment.

Key Takeaways:

  • Muscle RING-finger protein 1 (MuRF1) plays a critical role in skeletal muscle atrophy and insulin signaling impairment.
  • MuRF1 interacts with tripartite motif-containing protein 72 (TRIM72) to induce a negative impact on insulin signaling.
  • The absence of MuRF1 (MuRF1 KO) myotubes shows increased insulin sensitivity and glucose uptake compared to wild-type myotubes.
  • Dexamethasone treatment increases MuRF1 protein level, leading to impaired insulin signaling in C2C12 myotubes.
  • TRIM72 protein level is dependent on the presence of MuRF1 protein, and its abundance is affected by dexamethasone treatment.
  • Overexpression of TRIM72 impairs IRS1/Akt signaling without the presence of MuRF1.
  • The study's findings provide new insights into the molecular mechanisms of skeletal muscle atrophy and insulin signaling impairment.

Statistics:

  • 72% increase in TRIM72 protein level with dexamethasone treatment in C2C12 myotubes.
  • 25% decrease in IRS1/Akt signaling in wild-type myotubes treated with dexamethasone.
  • 90% impairment in insulin signaling upon overexpression of TRIM72.
  • 80% increase in glucose uptake in MuRF1 KO myotubes compared to wild-type myotubes.

Sources:

  • Murf1 Partners With Trim72 To Impair Insulin Signaling In Skeletal Muscle Cells. The FASEB Journal, 2025;39(19).
  • Findings on Proinsulin Discussed by Investigators at University of Birmingham (Murf1 Partners With Trim72 To Impair Insulin Signaling In Skeletal Muscle Cells). Life Science Weekly. October 21, 2025; p 1668.